Built for PSX investors
Your market watch, portfolio and news desk in one app.
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
Built for PSX investors
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
BFBIO published a PSX filing on Oct 7, 2026, 2:09 PM. Open the original source document for full details.
BF Biosciences Limited will hold its AGM on Wednesday, 28 October 2026 at 12:15 p.m. at Blue Lagoon, Masood Akhtar Kiani Road, Rawalpindi, and through video link. The agenda includes adoption of audited financial statements for the year ended 30 June 2026, appointment of auditors, and approval and authorization of related-party transactions. Share transfer books will be closed from 21 to 28 October 2026, inclusive.
BF Biosciences Limited will hold its Annual General Meeting on Wednesday, October 28, 2026 at 12:15 p.m. at Blue Lagoon, Masood Akhtar Kiani Road, Rawalpindi, and through video link. Business includes consideration of the audited financial statements for the year ended June 30, 2026, appointment of auditors, and a special resolution concerning related-party transactions.
For the year ended 30 June 2026, BF Biosciences reported revenue of Rs. 9.46 billion and profit after taxation of Rs. 632.13 million, up from Rs. 447.15 million in FY2025. EPS increased to Rs. 7.16 from Rs. 5.52.
The Company will conduct a board meeting to review financial results and declare entitlements.
BF Biosciences Limited has launched Continuous Glucose Monitoring devices in Pakistan, collaborating with SIBIONICS, enhancing diabetes management solutions.
The Annual Budget for FY 2026-27 has been approved by the Board of Directors of BF Biosciences Limited, requiring communication to TREC Holders.
A board of directors meeting is scheduled to discuss the annual budget for the financial year 2026-27.
BF Biosciences Ltd (BFBIO) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. Read company disclosures, financial-result notices, corporate actions and meeting updates. Open the relevant notice for its dates and terms.
This page brings together available disclosures for BF Biosciences Ltd (BFBIO), including results, corporate actions, meeting notices and other company updates. Open an individual announcement to read its details and available source document.
Look for the relevant financial-result or corporate-action announcement. Check its reporting period, dividend amount and any conditions in the notice; publication date is not necessarily the payment or entitlement date.
A future date should only be taken from an announcement that explicitly states it. Past payment dates or a historical dividend yield do not establish the next payout or book-closure schedule.
Use the Fundamentals section for available earnings, dividend and valuation figures, keeping each reporting period in view.
BFBIO financial results and fundamentalsPSX guides
What results, payouts, board meetings and other PSX disclosures mean for investors.
A practical PSX company research checklist for beginners: read stock pages, fundamentals, charts, technicals, announcements, annual reports and market news before buying.
Read guide
A plain-English guide to how capital gains tax (CGT) and dividend tax work on Pakistan Stock Exchange shares - filer vs non-filer rates, how holding period and acquisition date matter, how NCCPL collects CGT, and what you still have to declare.
Read guide
A beginner-friendly PSX guide comparing dividend stocks and growth stocks, including risks, investor fit, sectors, interest rates and market cycles.
Read guideData source: Market data is provided under a Pakistan Stock Exchange data license held by Recube Technologies (investify.pk), listed on the official PSX services page. Quotes, charts and derived figures are for information only and may be delayed, adjusted or revised by the exchange.
Not financial advice: Investify is not a brokerage and does not provide investment, trading or financial advice. Nothing on this page is a recommendation to buy or sell any security. Do your own research or consult a licensed advisor before making investment decisions. Read our data & editorial policy.
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
